Outlook Therapeutics Inc (NASDAQ:OTLK) has a beta value of 0.24 and has seen 1.22 million shares traded in the last trading session. The company, currently valued at $99.42M, closed the last trade at $2.32 per share which meant it gained $0.25 on the day or 12.08% during that session. The OTLK stock price is -298.71% off its 52-week high price of $9.25 and 62.5% above the 52-week low of $0.87.
The consensus among analysts is that Outlook Therapeutics Inc (OTLK) is Buy stock at the moment, with a recommendation rating of 1.50. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 5 have rated it as a Hold, with 5 advising it as a Buy. 0 have rated the stock as Underweight.
Outlook Therapeutics Inc (NASDAQ:OTLK) trade information
Sporting 12.08% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the OTLK stock price touched $2.32 or saw a rise of 1.28%. Year-to-date, Outlook Therapeutics Inc shares have moved -69.51%, while the 5-day performance has seen it change 24.73%. Over the past 30 days, the shares of Outlook Therapeutics Inc (NASDAQ:OTLK) have changed 29.61%.
Outlook Therapeutics Inc (OTLK) estimates and forecasts
The company’s shares have gained 6.42% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 36.59% over the past 5 years.
OTLK Dividends
Outlook Therapeutics Inc is expected to release its next earnings report in August this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Outlook Therapeutics Inc (NASDAQ:OTLK)’s Major holders
The top two institutional holders are GREAT POINT PARTNERS LLC with over 1.7 million shares worth more than $12.56 million. As of 2024-06-30, GREAT POINT PARTNERS LLC held 7.3255% of shares outstanding.
The other major institutional holder is TANG CAPITAL MANAGEMENT LLC, with the holding of over 1.62 million shares as of 2024-06-30. The firm’s total holdings are worth over $11.95 million and represent 6.9721% of shares outstanding.
